Ferring and PharmaBiome enter into a new microbiome R&D collaboration and exclusive licensing agreement

Press ReleaseAllNews
Written By PharmaBiome Webmaster
 
Microbiome

Ferring Pharmaceuticals and microbiome translation company PharmaBiome are today announcing a research & development collaboration to drive forward new microbiome-based biotherapeutics in the field of gastroenterology.

Link to Ferring Webpage
Download Press Release
 
Show all News & Press Releases
PharmaBiome Webmaster
Previous

Stratifying Gut Microbiomes by Succinotype: A Link to Inflammatory Bowel Disease
Next

TEDxZurich: How do you rebuild gut health?